+1-4012094076
info@celnovte.com
En
EN CN
Home NEWS & EVENTS

News & Event

Visit Celnovte at USCAP 113th Annual Meeting, Booth 553

19

2024.03

Visit Celnovte at USCAP 113th Annual Meeting, Booth 553

Celnovte, a leading pathology brand in China, is attending USCAP in 2024. Visit at at Booth 553. USCAP’s annual meeting is the largest gathering of pathologists in the world! Catch up on groundbreaking research; learn first-hand from pathology legends; network with your peers; see what’s new in the exhibit hall; delve deep into your specialty or gain a broader knowledge base: it all happens here.

Celnovte Showcase at Medlab 2024

18

2024.02

Celnovte Showcase at Medlab 2024

For the third consecutive year, Celnovte Biotechnology was featured at Medlab 2024, where we showcased our comprehensive pathology solutions tailored for histology, immunohistochemistry, cytology, and in situ hybridization (ISH).

Celnovte's CD138(C5G6) on Automatic IHC stainer CNT360 is honored as recommendation from NordiQC

19

2024.01

Celnovte's CD138(C5G6) on Automatic IHC stainer CNT360 is honored as recommendation from NordiQC

Fully Automatic IHC stainer CNT360
🔬60 slides throughput
🔬2.5hrs turn around time
🔬IHC, ISH, ICC support
🔬Romote control support
🔬LIS system support
Check our more at: info@celnovte.com

 New Product - Fast Frozen IHC solution

08

2023.12

 New Product - Fast Frozen IHC solution

Celnovte Fast Frozen Kits offers doctors a rapid detection and patients better patient care.

Celnovte Biotechnology Shines at Medica 2023

17

2023.11

Celnovte Biotechnology Shines at Medica 2023

Dusseldorf, Germany – Celnovte Biotechnology celebrated a successful showcase at Medica 2023, receiving enthusiastic praise for its innovative solutions in pathology diagnostic.

🎂Happy 13th Birthday to Celnovte Biotechnology🎂

18

2023.10

🎂Happy 13th Birthday to Celnovte Biotechnology🎂

Celnovte deeply appreciates the unwavering support of all our partners over these years. Let's embark on the journey ahead, working together for the next 13 years to achieve our vision of becoming a 100-year of enterprise!

0